Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Sections 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Iron(iii) Sodium Gluconate Complex (b03ac07) Within The Framework Of A So-called Open Hous 2026-09-30
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Sections 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Paliperidone (n05ax13) And The Trade Name Trevicta® Within The Framework Of A So-called Op 2026-09-30
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Social Security Code V For Medicinal Products Containing The Active Ingredients Dienogest And Estrogen (g03fa15) Within The Framework Of A So-called Open 2026-09-30
Germany Medicines Containing The Active Ingredient Bosutinib (atc 2026-09-30
Germany Medicines Containing The Active Ingredient Bosutinib (atc: L01ea04) 2026-09-30
Germany Aokpriomed Outpatient Heart Surgery Contract According To § 140a Sgb V 2026-09-30
Germany Drug Discount Agreements From 01.12.2024 For Various Active Ingredients Within The Framework Of An Open House Procedure 2026-10-01
Germany Pharmaceutical Discount Agreements From 01.12.2024 For Various Active Ingredients Within The Framework Of An Open-house Procedure 2026-10-01
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Sections 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Brinzolamide And Brimonidine (s01ec24) Within The Framework Of A So-called Open-house Mod 2026-10-01
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Sections 130a (8) And 130c (1) Sgb V For Medicinal Products Containing The Active Ingredients Dienogest And Estrogen (g03fa15) Within The Framework Of A So-called Open-house Model. 2026-10-01
Whats app